T-Net19h
UBC Spinoff NanoVation Therapeutics Announces Monster $815M Multi-Target Partnership With Novo Nordisk to Develop Genetic Medicines
Vancouver-based NanoVation Therapeutics, a UBC spinoff and platform company developing innovative technologies to overcome ...
T-Net21h
UBC Spinoff Company NanoVation Therapeutics Announces Monster $815M Multi-Target Partnership With Novo Nordisk to Develop Genetic Medicines
Vancouver-based NanoVation Therapeutics, a UBC spinoff and platform company developing innovative technologies to overcome ...
T-Net3h
Vancouver-based Venture Capital Firm Pangaea Ventures Announces Final Close of Fifth Fund at $85 Million
Pangaea Ventures, a pioneering venture capital firm dedicated to catalyzing hard tech solutions for a sustainable future, announced the successful final close of the Pangaea Ventures Impact Fund, ...
T-Net3h
Ondine Biomedical and MöLnlycke Announce Strategic Partnership to Market Steriwave Nasal Decolonization Technology
Ondine Biomedical Inc., a BC life sciences company pioneering light-activated antimicrobial treatments, and Mölnlycke Health Care (Gothenburg Sweden), a leading MedTech company that specializes in ...
T-Net3h
Vecima to Demonstrate Next Generation Fiber and Cable Access and Optimized, Efficient Video Delivery at SCTE TechExpo 2024
Vecima Networks Inc. announced that it will showcase broadband access and IPTV industry leadership at the SCTE TechExpo 2024, highlighting its Entra® Access portfolio, which enables operators to ...
T-Net4h
EnWave Reaches Civil Litigation Settlement with Former CEO and Others
EnWave Corporation announced that it has reached global settlements of its civil claim in the Supreme Court of British Columbia against EnWave's former CEO, Timothy Durance, as well as three other ...